Aug 18 (Reuters) - Corline Biomedical AB CLBIO.ST :
* POTENTIAL CUSTOMER IN USA CEASES OPERATIONS
* IN 2021, CORLINE SIGNED TERM SHEET WITH SMALLER CALIFORNIA-BASED COMPANY FOR CHS
MODIFICATION OF
IMPLANTS BEING DEVELOPED FOR TREATMENT OF VENOUS INSUFFICIENCY
* FUTURE POTENTIAL WAS STATED TO BE SEK 50 MILLION IN ANNUAL REVENUE
* HAS NOW RECEIVED INFORMATION THAT BOARD OF DIRECTORS OF CUSTOMER COMPANY VOTED TO DISSOLVE
COMPANY'S OPERATIONS AS MAIN INVESTORS DO NOT BELIEVE THEY HAVE SUFFICIENT CAPITAL TO SUPPORT
BUSINESS
* THUS, TERM SHEET CEASES TO APPLY AND CORLINE IS WRITING OFF FUTURE EARNINGS POTENTIAL
Source text for Eikon: ID:nGNE2c8ZWF
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))